{
    "root": "34a017f7-6d67-2e6f-e063-6294a90a1c77",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Duloxetine",
    "value": "20250508",
    "ingredients": [
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "FD&C BLUE NO. 2",
            "code": "L06K8R7DQK"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50821"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST)",
            "code": "G4U024CQK6",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_26092"
        },
        {
            "name": "HYPROMELLOSES",
            "code": "3NXW29V3WO",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_53426"
        },
        {
            "name": "POTASSIUM HYDROXIDE",
            "code": "WZH3C48M4T",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32035"
        },
        {
            "name": "AMMONIA",
            "code": "5138Q19F1X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16134"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "TRIETHYL CITRATE",
            "code": "8Z96QXD6UM",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_168426"
        },
        {
            "name": "DULOXETINE HYDROCHLORIDE",
            "code": "9044SC542W",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_36808"
        }
    ],
    "indications": {
        "text": "duloxetine delayed-release capsule serotonin norepinephrine reuptake inhibitor ( snri ) indicated treatment following conditions : major depressive disorder ( mdd ) adults ( 1 ) generalized anxiety disorder ( gad ) adults pediatric patients 7 years age older ( 1 ) diabetic peripheral neuropathic pain ( dpnp ) adults ( 1 ) fibromyalgia ( fm ) adults ( 1 ) pediatric patients 13 years age older ( 1 ) chronic musculoskeletal pain adults ( 1 )",
        "doid_entities": [
            {
                "text": "major depressive disorder (DOID:1470)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1470"
            },
            {
                "text": "depressive disorder (DOID:1596)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1596"
            },
            {
                "text": "generalized anxiety disorder (DOID:14320)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_14320"
            },
            {
                "text": "anxiety (DOID:2030)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_2030"
            },
            {
                "text": "fibromyalgia (DOID:631)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_631"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "chronic musculoskeletal pain",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_120188"
            }
        ]
    },
    "contraindications": {
        "text": "\u2022 take duloxetine delayed-release capsules daily , without food . swallow whole ; crush , chew , open capsule . ( 2.1 ) indication starting dose target dose maximum dose mdd ( 2.2 ) 40 mg/day 60 mg/day acute treatment : 40 mg/day ( 20 mg twice daily ) 60 mg/day ( daily 30 mg twice daily ) ; maintenance treatment : 60 mg/day 120 mg/day gad ( 2.3 ) adults geriatric pediatrics ( 7 17 years age ) 60 mg/day 30 mg/day 30 mg/day 60 mg/day ( daily ) 60 mg/day ( daily ) 30 60 mg/day ( daily ) 120 mg/day 120 mg/day 120 mg/day dpnp ( 2.4 ) 60 mg/day 60 mg/day ( daily ) 60 mg/day fm ( 2.5 ) adults pediatrics ( 13 17 years age ) 30 mg/day 60 mg/day ( daily ) 60 mg/day chronic musculoskeletal pain ( 2.6 ) 30 mg/day 60 mg/day ( daily ) 60 mg/day discontinuing duloxetine delayed-release capsules : gradually reduce avoid discontinuation symptoms ( 2.8 , 5.7 )",
        "doid_entities": [],
        "orphanet_entities": [
            {
                "disease": "chronic musculoskeletal pain",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_120188"
            }
        ]
    },
    "warningsAndPrecautions": "duloxetine available delayed-release capsules following strength , color , imprint , presentations : 60 mg , body color : green , cap color : dark blue , cap imprint : 'lu ' , body imprint : 'q03 ' ndc : 70518-1244-00 ndc : 70518-1244-01 ndc : 70518-1244-02 packaging : 30 1 blister pack packaging : 60 1 bottle plastic packaging : 180 1 bottle plastic * equivalent duloxetine base store 25\u00b0c ( 77\u00b0f ) ; excursions permitted 15\u00b0 30\u00b0c ( 59\u00b0 86\u00b0f ) [ usp controlled room temperature ] . repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "concomitant maoi antidepressant duloxetine contraindicated duloxetine within 14 days stopping maoi antidepressant contraindicated linezolid intravenous methylene blue-treated patients , initiation duloxetine contraindicated ( 4 )",
    "indications_original": "Duloxetine delayed-release capsule is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of the following conditions: Major depressive disorder (MDD) in adults ( 1 ) Generalized anxiety disorder (GAD) in adults and pediatric patients 7 years of age and older ( 1 ) Diabetic peripheral neuropathic Pain (DPNP) in adults ( 1 ) Fibromyalgia (FM) in adults ( 1 )and pediatric patients 13 years of age and older ( 1 ) Chronic musculoskeletal pain in adults ( 1 )",
    "contraindications_original": "\u2022 Take duloxetine delayed-release capsules once daily, with or without food. Swallow whole; do not crush, chew, or open capsule. ( 2.1 ) Indication Starting Dose Target Dose Maximum Dose MDD ( 2.2 ) 40 mg/day to 60 mg/day Acute Treatment: 40 mg/day (20 mg twice daily) to 60 mg/day (once daily or as 30 mg twice daily); Maintenance Treatment: 60 mg/day 120 mg/day GAD ( 2.3 ) Adults Geriatric Pediatrics (7 to 17 years of age) 60 mg/day 30 mg/day 30 mg/day 60 mg/day (once daily) 60 mg/day (once daily) 30 to 60 mg/day (once daily) 120 mg/day 120 mg/day 120 mg/day DPNP ( 2.4 ) 60 mg/day 60 mg/day (once daily) 60 mg/day FM ( 2.5 ) Adults and Pediatrics (13 to 17 years of age) 30 mg/day 60 mg/day (once daily) 60 mg/day Chronic Musculoskeletal Pain ( 2.6 ) 30 mg/day 60 mg/day (once daily) 60 mg/day Discontinuing duloxetine delayed-release capsules: Gradually reduce dosage to avoid discontinuation symptoms ( 2.8 , 5.7 )",
    "warningsAndPrecautions_original": "Duloxetine is available as delayed-release capsules in the following strength, color, imprint, and presentations:\n                  60 mg, body color: green, Cap color: dark blue, Cap Imprint: 'LU', Body Imprint: 'Q03'\n                  \n                  \n                  NDC: 70518-1244-00\n                  NDC: 70518-1244-01\n                  NDC: 70518-1244-02\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  PACKAGING: 60 in 1 BOTTLE PLASTIC\n                  PACKAGING: 180 in 1 BOTTLE PLASTIC\n                  \n                  \n                  *equivalent to duloxetine base\n                  \n                  Store at 25\u00b0C (77\u00b0F); excursions permitted to 15\u00b0 to 30\u00b0C (59\u00b0 to 86\u00b0F) [see USP Controlled Room Temperature].\n                  \n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "Concomitant use of an MAOI antidepressant with duloxetine is contraindicated Use of duloxetine within 14 days of stopping an MAOI antidepressant is contraindicated In linezolid or intravenous methylene blue-treated patients, initiation of duloxetine is contraindicated ( 4 )",
    "drug": [
        {
            "name": "Duloxetine",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_36796"
        }
    ]
}